Despite a rebound in crude oil prices, the markets closed lower with the Dow falling 50 points to 16,279 as global economic concerns weighed on investors. Nasdaq slipped 3 points to 4,752.
On the upside
Radius Health (Nasdaq: RDUS) will webcast a safety and tolerability update of RAD1901 tomorrow.
CTI BioPharma (Nasdaq: CTIC) shareholders approved its 2015 equity incentive plan and amended its 2007 employee stock purchase plan.
ViiV Healthcare, a GlaxoSmithKline (NYSE: GSK) and Pfizer (NYSE: PFE) company, reported positive data from a Phase IIIb/IV STRIIVING study evaluating switching from an anti-retroviral therapy to a one-daily, fixed-dose dolute-gravir-based regimen.
On the downside
Shares of Companhia Siderurgica Nacional (NYSE: SID) extended its losses.
Falling crude oil prices weighed down shares of California Resources (NYSE: CRC) and Comstock Resources (NYSE: CRK).
Profit taking weighed down shares of Cemtrex (Nasdaq: CETX).
In the broad market, declining issues outpaced advancers by a margin of 7 to 5 on the NYSE and by more than 9 to 7 on Nasdaq. The broader S&P 500 slipped 3 points to 1,938. Bitcoin added $1 to $229.
Lower close despite rebound in crude oil
September 23, 2015 at 20:07 PM EDT